Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Stone

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Blood|June 15, 1994
Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progressR M Stone
AORN Journal|May 1, 1971
Resolved: preoperative careR M Stone
Current Opinion in Oncology|February 1, 1992
Hematopoietic growth factors and leukemiaR M Stone
Canadian Journal of Surgery. Journal Canadien De Chirurgie|October 25, 2000
Health care funding in surgical practice and the Canadian health care systemR M Stone
Seminars in Hematology|July 28, 2001
Postremission therapy in adults with acute myeloid leukemiaR M Stone
Leukemia Research|May 1, 1997
Bryostatin 1: differentiating agent from the depthsR M Stone
AORN Journal|March 1, 1972
Expanded role of the nurse--do we want it?R M Stone
Hospitals & Health Networks|September 28, 2001
Another tech 'must'R M Stone
Leukemia|March 21, 2003
Induction and postremission therapy: new agentsR M Stone
Hematology/Oncology Clinics of North America|April 1, 1990
Prolymphocytic leukemiaR M Stone
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Blood|June 15, 1994
Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progressR M Stone
AORN Journal|May 1, 1971
Resolved: preoperative careR M Stone
Current Opinion in Oncology|February 1, 1992
Hematopoietic growth factors and leukemiaR M Stone
Canadian Journal of Surgery. Journal Canadien De Chirurgie|October 25, 2000
Health care funding in surgical practice and the Canadian health care systemR M Stone
Seminars in Hematology|July 28, 2001
Postremission therapy in adults with acute myeloid leukemiaR M Stone
Leukemia Research|May 1, 1997
Bryostatin 1: differentiating agent from the depthsR M Stone
AORN Journal|March 1, 1972
Expanded role of the nurse--do we want it?R M Stone
Hospitals & Health Networks|September 28, 2001
Another tech 'must'R M Stone
Leukemia|March 21, 2003
Induction and postremission therapy: new agentsR M Stone
Hematology/Oncology Clinics of North America|April 1, 1990
Prolymphocytic leukemiaR M Stone
Pageof 11